{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:31:35Z","timestamp":1778682695830,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejphar.2024.176573","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T01:44:38Z","timestamp":1713491078000},"page":"176573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Angiotensin-converting enzyme inhibition prevents l-dopa-induced dyskinesia in a 6-ohda-induced mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"973","author":[{"given":"Hye-Yeon","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga Seul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Kyoung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0119-7218","authenticated-orcid":false,"given":"Jeong Hee","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6636-8359","authenticated-orcid":false,"given":"Kyoung-Shim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176573_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2024.176573_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106362","article-title":"Striatal astrocytes act as a reservoir for L-DOPA","volume":"9","author":"Asanuma","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176573_bib3","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s00415-013-6859-5","article-title":"Nocturnal hypertension and dysautonomia in patients with Parkinson's disease: are they related?","volume":"260","author":"Berganzo","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejphar.2024.176573_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jns.2007.08.028","article-title":"Motor complications in Parkinson disease: clinical manifestations and management","volume":"266","author":"Bhidayasiri","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2024.176573_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nbd.2014.10.017","article-title":"Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease","volume":"73","author":"Bortolanza","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2024.176573_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ejn.13482","article-title":"l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?","volume":"45","author":"Carta","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176573_bib7","doi-asserted-by":"crossref","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","article-title":"Normal aging induces A1-like astrocyte reactivity","volume":"115","author":"Clarke","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ejphar.2024.176573_bib8","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.4103\/1673-5374.313061","article-title":"Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study","volume":"16","author":"Contaldi","year":"2021","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM196803142781127","article-title":"L-dopa for parkinsonism","volume":"278","author":"Cotzias","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2024.176573_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/syn.21941","article-title":"l-DOPA-induced dyskinesia in Parkinson's disease: are neuroinflammation and astrocytes key elements?","volume":"70","author":"Del-Bel","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2024.176573_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-022-02587-8","article-title":"Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis","volume":"19","author":"Dong","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2024.176573_bib12","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1096\/fj.11-182873","article-title":"Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease","volume":"25","author":"Dong","year":"2011","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2024.176573_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12987-022-00365-5","article-title":"Microglia-derived CCL2 has a prime role in neocortex neuroinflammation","volume":"19","author":"Errede","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ejphar.2024.176573_bib14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.expneurol.2013.10.013","article-title":"Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells","volume":"250","author":"Garrido-Gil","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.176573_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00429-012-0402-9","article-title":"Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra","volume":"218","author":"Garrido-Gil","year":"2013","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.ejphar.2024.176573_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42826-022-00134-3","article-title":"Humulus japonicus attenuates LPS-and scopolamine-induced cognitive impairment in mice","volume":"38","author":"Go","year":"2022","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib17","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/00029330-200811020-00019","article-title":"Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease","volume":"121","author":"Hou","year":"2008","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.ejphar.2024.176573_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2024.176573_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1471-4159.1999.0730214.x","article-title":"Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse","volume":"73","author":"Jenkins","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2024.176573_bib20","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1111\/ene.15964","article-title":"Collaborative plasma biomarkers for Parkinson disease development and progression: a cross-sectional and longitudinal study","volume":"30","author":"Jiao","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2024.176573_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003495-199000391-00005","article-title":"Biochemistry and pharmacology of the renin-angiotensin system","volume":"39","author":"Johnston","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2024.176573_bib22","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/mds.27783","article-title":"Predictors of motor complications in early Parkinson's disease: a prospective cohort study","volume":"34","author":"Kelly","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2024.176573_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0009-8981(94)90259-3","article-title":"Increased angiotensin-converting enzyme activity in cerebrospinal fluid of treated patients with Parkinson's disease","volume":"231","author":"Konings","year":"1994","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2024.176573_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1179\/016164104225015949","article-title":"Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice","volume":"26","author":"Kurosaki","year":"2004","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib25","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4014\/jmb.2205.05032","article-title":"Agathobaculum butyriciproducens shows neuroprotective effects in a 6-OHDA-induced mouse model of Parkinson's disease","volume":"32","author":"Lee","year":"2022","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejphar.2024.176573_bib26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cell.2015.08.029","article-title":"SnapShot: astrocytes in Health and disease","volume":"162","author":"Liddelow","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.176573_bib27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2024.176573_bib28","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbrc.2016.12.034","article-title":"Nurr1 overexpression exerts neuroprotective and anti-inflammatory roles via down-regulating CCL2 expression in both in vivo and in vitro Parkinson's disease models","volume":"482","author":"Liu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2024.176573_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2024.176573_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jnr.20598","article-title":"Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism","volume":"81","author":"Lopez-Real","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2005.02.002","article-title":"Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia","volume":"194","author":"Lundblad","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.176573_bib32","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1021\/acs.jproteome.0c01002","article-title":"Complement and coagulation cascades are potentially involved in dopaminergic neurodegeneration in alpha-synuclein-based mouse models of Parkinson's disease","volume":"20","author":"Ma","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.expneurol.2016.09.013","article-title":"Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease","volume":"286","author":"Mulas","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.176573_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-018-1100-1","article-title":"The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor","volume":"15","author":"Neal","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2024.176573_bib35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","article-title":"The intersection between aging and cardiovascular disease","volume":"110","author":"North","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3233\/JAD-150868","article-title":"Enalapril alone or Co-administered with losartan rescues cerebrovascular dysfunction, but not mnemonic deficits or amyloidosis in a mouse model of Alzheimer's disease","volume":"51","author":"Ongali","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejphar.2024.176573_bib37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.neuroscience.2009.01.034","article-title":"Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease","volume":"159","author":"Padovan-Neto","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2024.176573_bib38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1073858404264678","article-title":"Brain angiotensin II and synaptic transmission","volume":"10","author":"Pan","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ejphar.2024.176573_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12974-017-0830-9","article-title":"Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes","volume":"14","author":"Parillaud","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2024.176573_bib40","doi-asserted-by":"crossref","first-page":"11744","DOI":"10.1523\/JNEUROSCI.0864-14.2014","article-title":"Inhibition of adenylyl cyclase type 5 prevents L-DOPA-induced dyskinesia in an animal model of Parkinson's disease","volume":"34","author":"Park","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176573_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2016.02.013","article-title":"Gadd45beta ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model","volume":"89","author":"Park","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2024.176573_bib42","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/13543784.2017.1371133","article-title":"Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease","volume":"26","author":"Perez-Lloret","year":"2017","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2024.176573_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.ph.49.030187.002213","article-title":"Functions of angiotensin in the central nervous system","volume":"49","author":"Phillips","year":"1987","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2024.176573_bib44","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176573_bib45","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4049\/jimmunol.1700713","article-title":"Role of CD44 in regulating TLR2 activation of human macrophages and downstream expression of proinflammatory cytokines","volume":"200","author":"Qadri","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2024.176573_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1445-5994.2000.tb01054.x","article-title":"The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease","volume":"30","author":"Reardon","year":"2000","journal-title":"Aust. N. Z. J. Med."},{"key":"10.1016\/j.ejphar.2024.176573_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108173","article-title":"Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging","volume":"175","author":"Ryu","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.176573_bib48","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s12035-017-0752-7","article-title":"Metformin inhibits the development of L-DOPA-induced dyskinesia in a murine model of Parkinson's disease","volume":"55","author":"Ryu","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2024.176573_bib49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3892\/mmr.2021.11856","article-title":"beta-Lapachone ameliorates L-DOPA-induced dyskinesia in a 6-OHDA-induced mouse model of Parkinson's disease","volume":"23","author":"Ryu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2024.176573_bib50","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/jnc.15806","article-title":"Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders","volume":"166","author":"Santiago","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2024.176573_bib51","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1016\/j.biomaterials.2014.05.008","article-title":"The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation","volume":"35","author":"Sawyer","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejphar.2024.176573_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2018.04.031","article-title":"Cardiac abnormalities in Parkinson's disease and Parkinsonism","volume":"53","author":"Scorza","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176573_bib53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.expneurol.2013.10.014","article-title":"The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism","volume":"250","author":"Sonsalla","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.176573_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01203-20","article-title":"Interferon-inducible GTPase 1 impedes the dimerization of rabies virus phosphoprotein and restricts viral replication","volume":"94","author":"Tian","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2024.176573_bib55","doi-asserted-by":"crossref","first-page":"29336","DOI":"10.1074\/jbc.M211973200","article-title":"IIGP1, an interferon-gamma-inducible 47-kDa GTPase of the mouse, showing cooperative enzymatic activity and GTP-dependent multimerization","volume":"278","author":"Uthaiah","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176573_bib56","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00441-006-0190-8","article-title":"The CNS renin-angiotensin system","volume":"326","author":"von Bohlen und Halbach","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106133","article-title":"CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease","volume":"177","author":"Wang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbr.2017.05.066","article-title":"Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation","volume":"332","author":"Xu","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2011.09.016","article-title":"Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats","volume":"1421","author":"Yamada","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2024.176573_bib60","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nature medicine"},{"key":"10.1016\/j.ejphar.2024.176573_bib61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1742-2094-8-129","article-title":"Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade","volume":"8","author":"Zawada","year":"2011","journal-title":"J. Neuroinflammation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T11:02:09Z","timestamp":1714820529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924002619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":61,"alternative-id":["S0014299924002619"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176573","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme inhibition prevents l-dopa-induced dyskinesia in a 6-ohda-induced mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176573"}}